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Abstract (208 words) 
Implementation of evidence-based cognitive behavioural therapy for psychosis (CBTp) 
remains low in routine services. The United Kingdom Improving Access to Psychological 
Therapies for people with Severe Mental Illness (IAPT-SMI) initiative aimed to address this 
issue. The project evaluated whether existing servic s could improve access to CBTp and 
demonstrate effectiveness using a systematic approach t  therapy provision and outcome 
monitoring (in a similar way to the Improving Access to Psychological Therapies (IAPT) 
model for people with anxiety and depression). 
We report the clinical outcomes and key learning points from the South London and 
Maudsley NHS Foundation Trust IAPT-SMI demonstration site for psychosis. 
Additional funding enabled increased therapist capaity within existing secondary care 
community mental health services. Self-reported wellbeing and psychotic symptom outcomes 
were assessed, alongside service use and social/occupational functioning.  
Accepted referrals/year increased by 89% (2011/12: n=106/year; 2012-2015: n=200/year); 
90% engaged (attended ≥5 sessions) irrespective of ethnicity, age and gender. The assessment 
protocol proved feasible, and pre-post outcomes (n=280) showed clinical improvements and 
reduced service use, with medium effects. 
We conclude that, with appropriate service structure, investment allocated specifically for 
competent therapy provision leads to increased and effective delivery of CBTp. Our 
framework is replicable in other settings and can inform the wider implementation of 
















Psychosis is a severe mental illness characterised by unusual beliefs (delusions) and 
experiences (hallucinations and other anomalous perce tions), and changes in cognitive, 
emotional and social functioning. It is distressing and disabling for sufferers and their 
families, and exacts high societal cost (Andrew, Knapp, McCrone, Parsonage, & 
Trachtenberg, 2012). The National Institute for Health nd Care Excellence (NICE) guideline 
for schizophrenia and psychosis recommends that CBTp is offered in conjunction with 
antipsychotic medication (National Institute for Health and Care Excellence, 2014). 
However, delivery in routine practice is low (Colling et al., 2017; The Schizophrenia 
Commission, 2012), partly due to unclear treatment pathways and insufficient therapist 
capacity (Ince, Haddock, & Tai, 2016), presenting a major implementation challenge. The 
IAPT-SMI initiative aimed to build on the success of IAPT for people with common mental 
illness (Clark et al., 2009; Clark, 2018) and flagship service provision (Peters et al., 2015) to 
improve access to NICE-recommended psychological therapies for people with severe mental 
illness (SMI) (bipolar affective disorder, personality disorders, psychosis) (Department of 
Health, 2011). The South London and Maudsley NHS Foundation Trust (SLaM) psychosis 
demonstration site set out to test whether access to CBTp could be improved and 
effectiveness demonstrated with: (i) appropriate servic  structure, (ii) trained staff, and (iii) 
routine outcome monitoring. 
 
Method 
Improving Access to Psychological Therapies for people with Severe Mental Illness (IAPT-
SMI) 
This initiative aimed to enhance delivery of psychological therapies within existing services 














additional financial resource for therapy and outcome monitoring. IAPT is an English 
programme that aims to increase the availability of NICE recommended, evidence-based 
psychological treatments. Key features of the IAPT model include: training therapists to 
agreed competence criteria, with close, expert clinical supervision; employing routine 
outcome monitoring; and offering easy access with a prescribed waiting time. The original 
IAPT initiative provided treatment for adults with depression and anxiety disorders. This 
template was used to develop models of care for people with long term conditions, including 
severe mental illness. Six IAPT-SMI demonstration sites ran from 1/11/12 to 31/3/16. They 
examined i) to what extent the outcomes of clinical tri s could be reproduced within routine 
services; and ii) how treatment pathways supported th  delivery of psychological therapies 
for these patients. Details of the methods have been r ported previously (Jolley et al., 2015), 
and are outlined below. 
 
Service and Referrals 
SLaM covers four London boroughs, with high rates of ethnic diversity, population 
movement, drug use, socio-economic deprivation, and psychosis incidence. SLaM services 
were organised within Clinical Academic Groups (CAGs), and the Psychosis CAG had four 
Care Pathways: Early Intervention (EI), Promoting Recovery (PR), Complex Care, and Acute 
Inpatient Care. The IAPT-SMI service operated in the EI and PR pathways, alongside 
existing psychological therapy provision in Early Intervention and the Community Mental 
Health Teams (CMHTs), and was coordinated by a standalo e psychological interventions 
clinic for patients with psychosis (PICuP) (Peters t al., 2015). The PR pathway served 
people with established psychotic disorders, and the EI pathway saw people with a first 
episode of psychosis. Psychological therapists in existing services worked sessionally in 














therapist complement was ten whole time equivalents.  Patients gave written consent for their 
measures to be used pseudonymously for service evaluation, approved by SLaM’s audit and 
evaluation committee (PSYCHLO-13-18).  
 IAPT-SMI therapists saw patients with psychosis whose needs could be met within a 
psychological therapy service (i.e. people who opted in to a talking intervention; could attend 
fairly reliably; and who did not present with very high levels of risk or chaotic behaviour). 
There were no other exclusion criteria, and patients were seen with interpreters when 
required. Therapy was offered flexibly, with a focus on engagement. Offers were carefully 
framed to avoid invalidating people who located their problems externally, for example, as 
‘help to manage current difficulties with other peole’, rather than ‘help with paranoia’. 
Referrals were accepted from primary and secondary care, with a self-referral option. 
Medical and social care needs were managed in the CMHT or primary care. 
 
Assessment 
Referrals were screened by senior clinical psychologists, and accepted referrals were 
contacted by an assessor who was independent of therapy delivery (graduate psychology 
assistant) to explain the service. Patients wishing to proceed (‘opting in’) were offered a 60-
90 minute pre-therapy assessment, and then therapists offered a first therapy appointment 
within three to four weeks. Independent assessments were repeated at three-months, end of 
therapy, and follow-up (mean 9.5 months, range 5-18m). A sessional measure was completed 
at every therapy appointment, with the therapist’s help if needed. 
 
Therapy 
CBTp is an adaptation of CBT for emotional disorders and draws on cognitive models of 














formulation of the person’s psychosis, and intervenes with the psychological processes that 
are maintaining distress and impeding recovery. Therapy is tailored to personal goals, and the 
therapeutic relationship is genuinely collaborative and characterised by explicit warmth and 
transparency (Brabban, Byrne, Longden, & Morrison, 2017). Therapy was offered to suit the 
person’s needs, aiming for at least 16 one-hour session  in line with NICE guidance. Sessions 
occurred weekly to fortnightly over six to nine months, usually in the referring team’s base or 
a central clinic. Therapy drew on a wide range of published manuals (e.g. Meaden, Keen, 
Aston, Barton, & Bucci, 2013; Anthony P. Morrison, 2002 [listed in Johns et al., 2014]; 
Anthony P. Morrison, 2017) and was adherent to the IAPT-SMI CBTp competence 
framework (Roth & Pilling, 2013). IAPT-SMI therapists were trained to competence, using 
standardised assessments of therapy skills (Fowler, Rollinson, & French, 2011). Training was 
usually 12-24 months of post-qualification, postgradu te study (Jolley et al., 2012), 
comprising 226 hours of teaching and supervision, 476 hours of clinical work, and 300 hours 
of assignment work. Within IAPT-SMI, group clinical supervision was provided weekly to 
fortnightly, with additional fortnightly to monthly individual supervision. This equated to 
approximately 0.7 supervisor hours per therapist per week for ongoing supervision. 
Supervisors were senior clinicians with 10-20 years of experience of training therapists and 
of providing CBTp within NHS services and randomised controlled trials.  
 
Measures 
IAPT-SMI implemented routine outcome monitoring across the service, including activity 
(referrals, waiting times), performance (outcomes, s rvice use), user experience and 
satisfaction. The IAPT-SMI outcomes battery comprised the four measures described below, 
together with patient experience questionnaires and the Euroqol group’s EQ5D (The EuroQol 














additionally report outcomes on the self-report Clinical Outcomes in Routine Evaluation-10 
(CORE-10) (Barkham et al., 2012), which generates a mean total distress score based on ten 
items, each rated from 0 to 4, ranging from 0 (healt y) to 40 (severe). A change of 5 points or 
more is considered reliable. Functional outcome was rated using IAPT criteria of engaged in 
meaningful activity (in a work, domestic, voluntary or academic setting) or unoccupied. 
Demographic, activity, and service use data were coll cted by self-report and from the 
electronic health record. Service use data comprised duration of mental health admissions 
(occupied bed days, OBDs) and number of days under a crisis team (crisis team days, CTDs), 
calculated as a mean/person/month. Self-reported ethnicity was dichotomised into Black and 
Minority Ethnic (BME) or other group (non-BME). 
 
IAPT-SMI clinical outcomes 
1. Choice of outcome in cognitive therapy for psychoses (CHOICE) (Greenwood et al., 2010): 
An 11-item version of this self-report measure was completed sessionally. Each item is rated 
from 0 (worst) to 10 (best), giving a mean total score ranging from 0 to 10. The CHOICE was 
determined a priori as the primary outcome measure for the psychosis demonstration sites, 
and reliable improvement / deterioration predetermined as a change of ≥1.45 in mean total 
score. The 11-item version was based on the highest loading items from the 34-item measure, 
and it has good reliability and validity.  
2. Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) (Tennant et al., 2007): Fourteen 
items on this self-report measure are rated from 1 (none of the time) to 5 (all of the time), 
yielding a total score ranging from 14 to 70. Sensitivity analyses suggest a change of ≥3 to 














3. Work and Social Adjustment Scale (WSAS) (Mundt, Marks, Shear, & Greist, 2002): Five 
self-report items rate functional impairment from 0 (low) to 8 (very severe), yielding a total 
score from 0-40. A reduction of ≥13 points is considered to represent reliable change.  
4. Psychotic Symptom Rating Scales (PSYRATS) (Haddock, McCarron, Tarrier, & Faragher, 
1999): This practitioner-administered structured interview of voices (11 items) and delusions 
(6 items) is completed with individuals with a recent history of the relevant symptom (during 
the past month), and each item is rated for increasing severity from 0 to 4. Voices (0-44) and 
delusions (0-24) scores are reported separately (PSYRATS-V and PSYRATS-D). 
 
Analyses 
The data were analysed using SPSS (version 22) and STATA (version 12). Outcomes are 
reported for therapy engagers (attended ≥5 sessions) from the start of the service on 01/11/2 
to the final reporting date of 31/03/16. Therapy dropout was defined a priori as attending 
fewer than five sessions, which was considered too few to receive a meaningful ‘dose’ of 
therapy (7). Therapy engagers did not differ signifcantly from dropouts on gender, ethnicity, 
care pathway or diagnosis; there was a near-significa t effect for age, and dropouts tended to 
be younger (see Table 1). Primary clinical outcome (CHOICE) and service use (OBDs, 
CTDs) data were collected for all engagers; functioning and secondary clinical outcomes 
(CORE-10, WEMWBS, WSAS, PSYRATS) were collected for those attending an 
assessment session. 
 Clinical outcome data were analysed by an independent statistician (MK) using linear 
mixed model analyses including all available data at each time point. Missing data can lead to 
biased estimates of the treatment effect. A recommended way to reduce potential bias is to 
analyse all the observed outcome data using a mixed model via the maximum likelihood 














(White, Horton, Carpenter, & Pocock, 2011). We included demographic variables of age, 
gender and ethnicity as covariates in all models to assess any potential impact of these factors 
on outcomes. We also controlled for predictors of missing data in outcomes. To investigate 
potential predictors, we created a binary indicator (0= no missing data, 1= at least one of four 
assessments missing) of missing data for each outcome and screened for predictors of 
missing data using a series of logistic regression analyses. Covariates that were statistically 
significant at the 5% level in the logistic models (reported below in Results) were controlled 
for in the respective analyses of the outcome data to minimise potential bias arising from 
missing data. The analyses of primary and secondary outcomes were performed using linear 
mixed effects models to take account of the longitudinal (clustered) nature of the data. 
Random effects for clinical team (EI, CMHT, PICuP) and participant were tested; the former 
was not significant and was dropped from the analyses. The effectiveness of CBTp was tested 
by comparing pre-therapy with mid-therapy (3 month assessment), post-therapy (end of 
therapy assessment or last sessional CHOICE), and follow-up (where available). 
Comparisons between mid- and post-therapy and between post-therapy and follow-up were 
also tested using Stata’s ‘lincom’ command following the estimation of the linear mixed 
models. Effect sizes (ES) were calculated using the user contributed Stata command ‘cohend’ 
(Tannenbaum, 2011), and we report Cohen’s d corrected for uneven groups (due to missing 
data at the different time points). All outcome data were analysed, followed by subset 
analysis by care pathway (EI or PR) using a Time x Pathway interaction. 
 Wilcoxon matched-pair signed-rank tests and the McNemar test were used to assess 
the significance of change in service use (OBDs, CTDs) and functional outcome, 
respectively, over the course of therapy. Within-participant effect sizes (ES, Cohen’s d) were 
















Referrals and therapy completion 
On the final day of reporting (31/10/15), there were 5602 people with psychosis being treated 
in the PR pathway and 767 in the EI pathway. During the referral period (1/11/12 - 31/10/15), 
703 people were referred for CBTp within IAPT-SMI, and 599 (85%) were accepted as 
appropriate referrals. Accepted referrals of 200/year over 2012-2015 compared with 106 in 
the year before IAPT-SMI, an increase of 89%. Eight-six percent (514/599) of accepted 
referrals opted in, 89% (456/514) of these attended th ir assessment, and 88% (402/456) of 
these had started therapy by the end of the referral pe iod (67% of the original 599 accepted 
referrals). Those who were not offered therapy opted out after the assessment (n=39) or were 
referred to or given details of an alternative, more suitable service (n=15). Referrals and 
attrition are shown in Figure 1. Mean time from refe ral to assessment was 37 days (SD 
27.7), and from assessment to first therapy session was 64 days (SD=57). These waiting 
times include time to arrange appointments and accomm dation of patient preferences and 
cancellations. By 31/03/16, 342 cases had completed their involvement with IAPT-SMI: 303 
engagers (75% of those starting); and 39 (9.7%) who dropped out (received <5 sessions). 
Fifty-eight were either still in therapy (n=48) or had not completed for other reasons (n=10). 
Therapy engagers attended, on average, 18 sessions (SD=8.1) over 8 months (SD=4). A full-
time therapist completed therapy with 20 patients per year, with a caseload of 15 patients at 
any one time and weekly therapy sessions. Demographic data, care pathways, and diagnoses 
of completed cases are shown in Table 1. 
Figure 1 and Table 1 here 
 














The paired completion rate (first-last CHOICE over the course of therapy) was 93% (n=280). 
Predictors of missing CHOICE data were diagnosis and pre-therapy WSAS and WEMWBS 
(higher WSAS and WEMWBS scores, and ‘other’ diagnosis predicted fewer missing data).  
These covariates were controlled for in the analysis to minimise any potential bias. Therapy 
engagers improved during therapy, with increased post-therapy (or last sessional) scores 
(ES=0.7), which were maintained at follow-up (ES=0.5). There were no significant 
differences between EI and PR for any of the comparisons, and no effects of the demographic 
covariates on outcomes. Forty nine percent of therapy completers showed reliable 
improvement on the CHOICE (mean score increased by ≥1.45). Fourteen (5%) showed 
reliable deterioration (mean score reduced by ≥1.45), but none required admission or crisis 
team referral.   
Table 2 here 
 
Secondary clinical outcomes (Table 3) 
Missing data predictors were: diagnosis and pre-therapy employment status for WEMWBS; 
diagnosis, pre-therapy employment status and WEMWBS scores for WSAS; and diagnosis 
for PSYRATS-V. Higher WEMWBS scores, not engaged in meaningful activity, and ‘other’ 
diagnosis predicted fewer missing data. These were controlled for in the respective analyses 
to reduce any potential bias arising from missing data. Paired completion rates on the 
measures (pre-post therapy) ranged from 80-86%. Baseline scores indicated moderate levels 
of distress and functional impairment, and low subjective wellbeing. Sixty percent of patients 
reported current positive psychotic symptoms (voices and/or delusions). There were 
significant improvements on all measures during therapy (ES= 0.45-1.00), most of which 
were maintained at follow-up (ES= 0.3-0.75). Therapy engagers reported reduced levels of 














and delusions. There was a significant pathway difference only for PSYRATS-V scores 
(Time x Pathway interaction p= 0.015): the improvement was greater in the EI group post-
therapy, and the improvement within the PR group was not maintained in the follow-up 
sample. 
Table 3 here 
 
Service use 
Paired service use data were available for all therapy engagers. Average use/person/month in 
the year preceding therapy was 0.8 occupied bed days (OBDs) (SD=2.2, range 0-14) and 0.5 
crisis team days (CTDs) (SD=1.5, range 0-15), which reduced to 0.2 OBDs (SD=1.2, range 
0-12) and 0.1 CTDs (SD=0.5, range 0-5) during therapy (Wilcoxon matched-pair signed-rank 
test, p<0.001; OBDs: d=0.45; CTDs: d=0.4). 
 
Functioning outcomes 
Paired outcomes were available for 89% of therapy engagers (n=269). Improvement (from 
unoccupied to meaningful activity) was reported by 18.5% (n=50), no change for 74.5% 
(n=200), and a reduction in activity (from meaningful to unoccupied) for 7% (n=19). There 
was a significant change in the proportion of patients engaged in meaningful activity before 
and after therapy, with a net change of 31 patients from unoccupied to activity (related 
samples McNemar test, p<0.001). 
 
Discussion 
CBTp is recommended by clinical guidelines, but delivery in routine services is low. The 
demonstration site showed that it is possible to enhance delivery of NICE-concordant CBTp 














effectiveness with routine outcome monitoring. The large number of patients who were 
referred and who opted-in showed that demand for CBTp is high. Three main factors 
facilitated increased access (Jolley et al., 2015).  Firstly, SLaM Trust was organisationally 
ready to be a demonstration site, with strong clinial leadership and a critical mass of staff 
trained to deliver and supervise CBTp to a high standard. Secondly, funding was ring-fenced 
(i.e. restricted for IAPT-SMI use) and could be transl ted almost immediately into increased 
delivery by the creation of dedicated psychological therapist posts. With regard to treatment 
pathways, therapy provision was embedded in the team within Early Intervention, facilitating 
engagement with patients. In Promoting Recovery, IAPT-SMI provided a separate-but-linked 
psychology service (people who were ambivalent about therapy, or engaged erratically, were 
offered psychological therapy within their Community Mental Health Team). Thirdly, the 
specialised focus of the service meant that all staff understood the difficulties facing people 
with psychosis, and how to accommodate these to engage clients in therapy. The findings are 
consistent with previous reports (Ince et al., 2016) that a lack of skilled therapist capacity and 
appropriate service structure contribute to poor imple entation, rather than a lack of demand 
for CBTp. The large number of patients with psychosis in the treatment pathways highlights 
the size of the need and, despite its success, IAPT-SMI still only saw a percentage of the total 
caseload. 
 The site demonstrated effectiveness of CBTp using routine outcome monitoring. 
Changes on the primary outcome measure compare favourably with those in IAPT services 
for people with Common Mental Illness, with medium to large pre-post effect sizes (Clark et 
al., 2009; Gyani, Shafran, Layard, & Clark, 2013). Pre-post changes on secondary measures 
and the effect sizes are comparable to other effectiveness studies of CBTp in clinical services 
(Lincoln et al., 2012; A. P. Morrison et al., 2004; Peters et al., 2015). In addition, reductions 














potential for cost-effective delivery. Our results provide further evidence that it is possible to 
reproduce the therapy outcomes of clinical trials within routine services. In particular, the site 
delivered CBTp and achieved good outcomes at scale a ross an IAPT-SMI service that 
included community teams in addition to a specialised psychological therapies service. The 
patients were symptomatic, presenting with psychoti symptoms and/or emotional problems 
of moderate severity. Our patient group had rates of thnic variation similar to those of our 
catchment areas, and we found no significant demographic inequity in therapy engagement or 
primary outcome. 
  Routine outcome monitoring was feasible and acceptable to patients. Assistant 
psychologists conducted pre, mid- and post-therapy assessments, which reduced the burden 
on therapists. The initial assessment also served as a cost-effective triage system, reducing 
therapist time spent chasing referrals who eventually opted-out. Rates of attendance at post-
therapy assessments were good for engagers (80%), showing that patients are willing to 
complete assessments. The sessional measurement achieved the high rates of paired outcomes 
obtained in IAPT-CMI (>90%). Patients mostly found outcome monitoring satisfactory 
(Fornells-Ambrojo et al., 2017), and sharing this information helped to allay therapists’ 
reservations about sessional measurement.  
 
 Limitations 
The primary limitations of the evaluation are its site-specificity and the uncontrolled design. 
Assessments were independent of therapy but not blind, and the primary outcome measure 
was novel. Reported effects are within-participant and pre-post, so we cannot infer that 
changes definitely occurred as a result of therapy, lthough findings from the PICuP service 
using a similar design have shown no changes during a waiting list period (Peters et al., 














between-group or meta-analytic effect sizes for CBTp, which range from 0.2 to 0.4. Follow-
up assessments were only implemented across the service 18-months into the pilot, and there 
was loss to follow-up, especially in the Early Intervention group. Hence, we cannot assume 
that the maintenance of therapy gains in the follow-up sample would generalise to the rest of 
the patient group.  
 
Implications 
The challenge within the NHS is to deliver, at scale, evidence-based therapies that reproduce 
the outcomes achieved in therapy trials. This IAPT-SMI demonstration site demonstrated that 
a systematic approach, whereby psychological therapi s are prioritised and evaluated, can 
operate effectively in routine community services, within or alongside the CMHT, and can 
produce good clinical outcomes. Our experience show that once referral pathways and 
expert supervision structures are established, the recruitment of well-trained, or trainable, 
therapists into specialist posts will result in increased and potentially cost-effective delivery. 
 The UK Early Intervention in Psychosis Access and Waiting Time Standard (NHS 
England, the National Collaborating Centre for Mental Health, & National Institute for 
Health and Care Excellence, 2016) has facilitated access to CBTp within EI teams through 
additional funding for posts and training. However, there remains a need to support dedicated 
therapy posts in teams, and to ensure that therapists who complete CBTp training have the 
time to deliver therapy. Previous attempts to train up case managers have had limited success, 
due to lack of protected time (Brooker & Brabban, 2004), and widening access to 
psychological therapies requires roles that are dedicated, at least in part, to therapy delivery 
(Garety et al., 2018). Our findings can inform the work of NHS England to meet the 
commitments set out in the Five Year Forward View for Mental Health (NHS England, 2016) 














mental illness. The IAPT-SMI approach is also compatible with the Coordinated Specialty 
Care (CSC) model for first episode psychosis in the US (Heinssen, Goldstein, & Azrin, 
2014), and offers a framework for therapy provision and evaluation within the CSC program. 
With the key facilitators of implementation in place, new investment translates readily into 
efficient and effective therapy delivery (Jolley, 2018). 
 
Conclusion: 
The SLaM IAPT-SMI demonstration site showed that NICE-recommended individual CBTp 
can be delivered successfully at scale in community services, with routine outcome 
monitoring, and good clinical outcomes. Our framework is replicable in other services. The 
first step is a therapist champion to facilitate organisational change and service development. 
Ready organisations can use funding to build a critical mass of supervisors and therapists to 
deliver therapy, and also to support further workforce development and therapy innovations. 
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  213 (62.5%) 
  29 (8.5%) 
  33 (9.5%) 




   188 (62.5%) 
25 (8%) 
  30 (10%) 




 25 (64%) 
   4 (10%) 
 3 (8%) 





2=0.4, df 3, 
p=0.94 
 

















Table 2: Primary clinical outcome for therapy engagers 






























































































<0.001 0.4 1.19 0.61-
1.77 
<0.001 0.5 0.77 0.48-
1.07 





<0.001 0.7 1.68 1.20-
2.16 
<0.001 0.9 1.51 1.25-
1.77 





<0.001 0.5 2.12 0.96-
3.27 
<0.001 0.7 1.19 0.84-
1.53 





<0.001 0.3 0.49 -0.10-
1.08 









0.10 0.2 0.44 -0.72-
1.59 














211 (75%) 56 (83.5%) 155 (73%) 
Reliable 
Improvement2 
137 (49%) 38 (56.5%) 99 (47%) 

















129 (46%) 26 (39%) 103 (48%) 
Any 
deterioration 
64 (23%) 10 (15%) 54 (25%) 
Reliable 
Deterioration2 
14 (5%) 3 (4.5%) 11 (5%) 
Between 
group (EI vs 
PR) χ2test 
 Any change: χ2=3.26 df=2, NS; Reliable change: χ2=2.15 df=2, NS. 
 

















Table 3: Secondary clinical outcomes for therapy engagers 
 
 Whole Sample 
Measure Unadjusted Mean 
(SD) 
Pre-post change 
Pre Mid Post Follow-
up 



















N=0 -4.59 -5.41 
to -
3.77 













7.57 6.26 to 
8.88 
< 0.001 0.65 4.24 2.41 to 
6.08 
















< 0.001 0.45 -3.81 -5.46 
to -
2.16 



































< 0.001 1.00 -4.23 -5.86 
to -
2.60 
< 0.001 0.75 
 
Key: CORE-10: Clinical Outcomes in Routine Evaluation (10 item) Barkham et al., 2013; WEMWBS: Warwick Edinburgh Mental Wellbeing 
Scale (Tennant et al., 2007); WSAS: Work and Social Adjustment Scale (Mundt et al., 2002); PSYRATS: Psychotic Symptoms Rating Scale 


















           IAPT-SMI Referrals 
 
  
Opted out: n= 41, (5 EI, 36 PR)   
Refused or missed initial 
assessment: n=5 (EI) 
Opted out:  
n= 74 (19 EI, 55 PR)  
Awaiting assessment: n=12 (PR) 
 
Awaiting opt-in:  
n= 11 (PR) 
Opted-in 
n= 514 









(139 EI, 564 PR) 
In progress: n=7 (PR) 
 
Accepted 
n= 599 (125 EI, 474 PR) 
Started therapy 
n= 402 
 (94 EI, 308 PR)  
 
Completed mid/3 month 
n= 248 (46 EI, 202 PR) 
Dropout (<5 sessions):  
n=39 (13 EI, 26 PR) 
Discontinued/lost to contact: 
n=10 (1 EI, 9 PR) 
Opted out: n= 39 (6 EI, 
33 PR) 
Referred on: n= 15 (PR) 
On hold/waiting: 
n=5 (1 EI, 4 PR) 
 
Referral not accepted n=97 (14 EI, 83 PR) 
1. No current or history of F2 spectrum 
psychosis n=11 (1 EI, 10 PR) 
2. PR: needs MDT input, or other service, 
or high risk n=62 
3. EI: offered therapy in team n= 11  
4. Out of area n=2 
5. Inpatient n=4 (2 EI, 2 PR)  
6. Other n=7 
Completed therapy  
n= 303 (74 EI, 229 PR) 
 
Therapy ongoing: n= 48 
(6 EI, 42 PR) 
On hold: n= 2 (PR) 
Completed follow-up 














• Individual CBTp delivered in routine services achieves good clinical outcomes 
• Only a small investment in therapy provision is needed for increased delivery 
• Strong clinical leadership is a key facilitator for implementation of CBTp at scale 
• Routine and sessional outcome measurement is acceptable to clients with psychosis 
• No demographic inequity in therapy engagement or primary outcome 
 
 
